These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28482661)

  • 1. Insights into Formation and Structure of Aβ Oligomers Cross-Linked via Tyrosines.
    Zhang S; Fox DM; Urbanc B
    J Phys Chem B; 2017 Jun; 121(22):5523-5535. PubMed ID: 28482661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the Role of Hydroxylated Phenylalanine in the Formation and Structure of Cross-Linked Aβ Oligomers.
    Zhang S; Fox DM; Urbanc B
    J Phys Chem B; 2019 Feb; 123(5):1068-1084. PubMed ID: 30642171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully Atomistic Aβ40 and Aβ42 Oligomers in Water: Observation of Porelike Conformations.
    Voelker MJ; Barz B; Urbanc B
    J Chem Theory Comput; 2017 Sep; 13(9):4567-4583. PubMed ID: 28727426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP).
    Williams TL; Serpell LC; Urbanc B
    Biochim Biophys Acta; 2016 Mar; 1864(3):249-259. PubMed ID: 26699836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers.
    Moore BD; Rangachari V; Tay WM; Milkovic NM; Rosenberry TL
    Biochemistry; 2009 Dec; 48(49):11796-806. PubMed ID: 19916493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
    Atwood CS; Perry G; Zeng H; Kato Y; Jones WD; Ling KQ; Huang X; Moir RD; Wang D; Sayre LM; Smith MA; Chen SG; Bush AI
    Biochemistry; 2004 Jan; 43(2):560-8. PubMed ID: 14717612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dityrosine cross-linked Abeta peptides: fibrillar beta-structure in Abeta(1-40) is conducive to formation of dityrosine cross-links but a dityrosine cross-link in Abeta(8-14) does not induce beta-structure.
    Yoburn JC; Tian W; Brower JO; Nowick JS; Glabe CG; Van Vranken DL
    Chem Res Toxicol; 2003 Apr; 16(4):531-5. PubMed ID: 12703970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways of Amyloid-β Aggregation Depend on Oligomer Shape.
    Barz B; Liao Q; Strodel B
    J Am Chem Soc; 2018 Jan; 140(1):319-327. PubMed ID: 29235346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico study of amyloid beta-protein folding and oligomerization.
    Urbanc B; Cruz L; Yun S; Buldyrev SV; Bitan G; Teplow DB; Stanley HE
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17345-50. PubMed ID: 15583128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Characterization of Chemically Stabilized Aβ42 Oligomers.
    Yamin G; Huynh TP; Teplow DB
    Biochemistry; 2015 Sep; 54(34):5315-21. PubMed ID: 26241378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of pure populations of covalently stabilized amyloid β-protein oligomers of specific sizes.
    Hayden EY; Conovaloff JL; Mason A; Bitan G; Teplow DB
    Anal Biochem; 2017 Feb; 518():78-85. PubMed ID: 27810329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Di-tyrosine cross-link decreases the collisional cross-section of aβ peptide dimers and trimers in the gas phase: an ion mobility study.
    Sitkiewicz E; Olędzki J; Poznański J; Dadlez M
    PLoS One; 2014; 9(6):e100200. PubMed ID: 24945725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrete molecular dynamics study of oligomer formation by N-terminally truncated amyloid β-protein.
    Meral D; Urbanc B
    J Mol Biol; 2013 Jun; 425(12):2260-75. PubMed ID: 23500806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of amyloid beta-protein oligomerization mechanisms: discrete molecular dynamics study.
    Urbanc B; Betnel M; Cruz L; Bitan G; Teplow DB
    J Am Chem Soc; 2010 Mar; 132(12):4266-80. PubMed ID: 20218566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.
    Ladiwala AR; Litt J; Kane RS; Aucoin DS; Smith SO; Ranjan S; Davis J; Van Nostrand WE; Tessier PM
    J Biol Chem; 2012 Jul; 287(29):24765-73. PubMed ID: 22547072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity.
    Jin L; Wu WH; Li QY; Zhao YF; Li YM
    Nanoscale; 2011 Nov; 3(11):4746-51. PubMed ID: 21952557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.